DXB 3.92% 53.0¢ dimerix limited

Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-49

  1. 1,195 Posts.
    lightbulb Created with Sketch. 119
    Thank you OvF

    Lets hope so and given that a relatively significant number of patients stayed on the drug post ph2 trials, then the more the merrier.

    I’m sweating on the Covid results due any day now.

    Not getting any younger!

    cheers
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
53.0¢
Change
0.020(3.92%)
Mkt cap ! $291.6M
Open High Low Value Volume
51.0¢ 53.8¢ 51.0¢ $782.0K 1.490M

Buyers (Bids)

No. Vol. Price($)
1 6408 53.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.5¢ 35657 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.